Defentect Group Stock Performance
| DFTC Stock | USD 0 0.0002 4.44% |
Defentect has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0053, which means not very significant fluctuations relative to the market. As returns on the market increase, Defentect's returns are expected to increase less than the market. However, during the bear market, the loss of holding Defentect is expected to be smaller as well. Defentect Group right now shows a risk of 6.41%. Please confirm Defentect Group information ratio, skewness, price action indicator, as well as the relationship between the treynor ratio and rate of daily change , to decide if Defentect Group will be following its price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Defentect Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal basic indicators, Defentect may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
Defentect |
Defentect Relative Risk vs. Return Landscape
If you would invest 0.43 in Defentect Group on April 27, 2025 and sell it today you would earn a total of 0.00 from holding Defentect Group or generate 0.0% return on investment over 90 days. Defentect Group is currently generating 0.1929% in daily expected returns and assumes 6.4084% risk (volatility on return distribution) over the 90 days horizon. In different words, 57% of pink sheets are less volatile than Defentect, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Defentect Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Defentect's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Defentect Group, and traders can use it to determine the average amount a Defentect's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0301
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DFTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.41 actual daily | 57 57% of assets are less volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Defentect is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Defentect by adding it to a well-diversified portfolio.
Defentect Fundamentals Growth
Defentect Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Defentect, and Defentect fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Defentect Pink Sheet performance.
| Return On Equity | -11.87 | |||
| Return On Asset | -1.15 | |||
| Operating Margin | (10.85) % | |||
| Current Valuation | 1.38 M | |||
| Shares Outstanding | 78.78 M | |||
| Price To Earning | (0.01) X | |||
| Price To Sales | 2.67 X | |||
| Revenue | 733.89 K | |||
| EBITDA | (3.1 M) | |||
| Cash And Equivalents | 2.99 K | |||
| Total Debt | 988.16 K | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (690.07 K) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 399.38 K | |||
| Retained Earnings | (10.61 M) | |||
| Current Asset | 169 K | |||
| Current Liabilities | 1.42 M | |||
About Defentect Performance
By analyzing Defentect's fundamental ratios, stakeholders can gain valuable insights into Defentect's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Defentect has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Defentect has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Defentect Group, Inc. develops and provides IP based alerting system that protects against chemical, biological, radiological, nuclear, and explosive threats. Defentect Group, Inc. was incorporated in 2000 and is based in New Canaan, Connecticut. Defentect operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about Defentect Group performance evaluation
Checking the ongoing alerts about Defentect for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Defentect Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Defentect Group had very high historical volatility over the last 90 days | |
| Defentect Group has some characteristics of a very speculative penny stock | |
| Defentect Group has a very high chance of going through financial distress in the upcoming years | |
| Defentect Group currently holds 988.16 K in liabilities. Defentect Group has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Defentect until it has trouble settling it off, either with new capital or with free cash flow. So, Defentect's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Defentect Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Defentect to invest in growth at high rates of return. When we think about Defentect's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 733.89 K. Net Loss for the year was (4.18 M) with profit before overhead, payroll, taxes, and interest of 34.28 K. | |
| Defentect Group currently holds about 2.99 K in cash with (690.07 K) of positive cash flow from operations. |
- Analyzing Defentect's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Defentect's stock is overvalued or undervalued compared to its peers.
- Examining Defentect's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Defentect's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Defentect's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Defentect's pink sheet. These opinions can provide insight into Defentect's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Defentect Pink Sheet analysis
When running Defentect's price analysis, check to measure Defentect's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defentect is operating at the current time. Most of Defentect's value examination focuses on studying past and present price action to predict the probability of Defentect's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defentect's price. Additionally, you may evaluate how the addition of Defentect to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |